Table 1 Patients’ characteristics and prior management
| Age median (range) | 51 (32–77) |
| Sex | |
| Male | 6 (46%) |
| Female | 7 (54%) |
| ECOG PS | |
| 0 | 2 (15%) |
| 1 | 9 (70%) |
| 2 | 2 (15%) |
| Primary location | |
| Thorax | 4 (31%) |
| Abdomen | 3 (24%) |
| Pelvis | 2 (15%) |
| Thigh | 2 (15%) |
| Others | 2 (15%) |
| Prior surgery | |
| Yes | 8 (62%) |
| No | 5 (38%) |
| Metastatic disease | |
| Yes | 10 (77%) |
| No | 3 (23%) |
| Site of metastases | |
| Lungs | 4 (31%) |
| Liver | 3 (24%) |
| Bone | 2 (15%) |
| Intra-abdominal | 2 (15%) |
| Kidney | 1 (8%) |
| Disease progression | |
| before pazopanib | 13 (100%) |